Nasdaq: URGN
UroGen Pharma insiders
The officers, directors and 10% owners of UroGen Pharma Ltd. who hold the most stock, valued at the live URGN price.
$31.73
URGN today +$1.9M (+6.51%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their URGN stock
- $25.6M
- Market value
- $1.56B
- Held by ranked insiders
- 1.64%
Insiders by value of URGN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Arie Belldegrun | Director | 408,693 | $13.0M | 0.83% | 5599th |
| 2 | Elizabeth A. Barrett | Chief Executive Officer | 326,691 | $10.4M | 0.67% | 8560th |
| 3 | Fred E. Cohen | Director | 69,339 | $2.2M | 0.14% | 6366th |
| 4 | Leana Wen | Director | 2,000 | $63K | <0.1% | 14288th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for UroGen Pharma; see each profile for the filing.